Safety is Sexy in Healthcare B2B Sales; Why Risk, Not Upside, Decides Deals

About this episode

The episode discusses how risk, rather than potential upside, is the primary factor influencing deals in healthcare B2B sales.

In healthcare B2B sales, the deal is often shaped before ROI is fully debated. It begins when a buyer asks a simpler question: what could go wrong? Healthcare sales is methodical, slow, and process heavy. Health systems are not optimized for novelty or speed alone. They are optimized to avoid harm while maintaining continuity of care. Safety may not sound exciting, but for anyone selling into a hospital or large health system, it is often where deals gain or lose momentum. Buyers are not primarily asking how much upside a solution creates. They are asking how much risk it introduces. That does not mean upside is irrelevant. It means upside is filtered through a risk lens.

People in this episode

Host: Paul Schrimpf

Topics covered

• healthcare sales
• B2B sales
• risk management
• ROI
• deal momentum

Keywords

• healthcare
• B2B sales
• risk
• ROI
• sales process
• deal momentum
• continuity of care

Mentioned in this episode

Organizations: healthcare, health systems

More episodes of Microdosing

• Dear Health Systems, Nobody ‘Wants’ to Use You · February 17, 2026 · 12 min
• Why the Future Belongs to Platforms, Plug-Ins, and Stacks · February 3, 2026 · 12 min
• The Innovation Gatekeeper - Fast-Cycle ROI; Why financial validation now needs to happen in 1–2 budget cycles, not 3–5 years · January 27, 2026 · 8 min
• The Innovation Gatekeeper - Fast-Cycle ROI; Why financial validation now needs to happen in 1–2 budget cycles, not 3–5 years · January 22, 2026 · 8 min
• The End of “One More Tool”; Why the Next Decade Belongs to Connectors, Integrators, and Platform Layers. · January 19, 2026 · 8 min
• Building a Better Backbone and the Role of Primary Care in the US · January 6, 2026 · 8 min